ASMB logo

Assembly Biosciences (ASMB) Company Overview

Profile

Full Name:

Assembly Biosciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 17, 2010

Indexes:

Not included

Website:

http://www.assemblybio.com

Description:

Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company is developing oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and a new class of oral synthetic live biotherapeutic candidates for microbiome-related disorders. It is involved in the development of core inhibitors that suppress the functional activity of the HBV core protein at various stages of the virus life cycle. The company was previously known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in South San Francisco, California.

Key Details

Price

$11.12

Market Cap

$70.68 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$7.16 M

Annual EPS

-$13.38(+42.03% YoY)

PE Ratio

-

Annual ROE

-98.95%

Annual Debt To Equity

0.00

Beta

-

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 12, 2024

Analyst ratings

Recent major analysts updates

Dec 27, 24 HC Wainwright & Co.
Neutral
Jun 20, 24 HC Wainwright & Co.
Neutral
Jun 13, 24 HC Wainwright & Co.
Neutral
Apr 1, 24 HC Wainwright & Co.
Neutral
Mar 24, 23 HC Wainwright & Co.
Neutral
Nov 16, 22 Mizuho
Buy
Oct 24, 22 Truist Securities
Hold
Apr 1, 22 Truist Securities
Buy
Sep 13, 21 HC Wainwright & Co.
Neutral
Sep 2, 21 William Blair
Market Perform

Screeners with ASMB included

Growing Shares Outstanding
US stocks
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
NASDAQ Listed Companies
Biotechnology industry
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$11.12
ASMB price is $11.12

Price All-time High

$1215.00
ASMB price is currently -99.08% below its historical high of $1215.00

Price Analysts Target

$35.50
ASMB price is currently -68.68% lower than the consensus analysts' forecast

Price Most Recent Change

-2.71%
ASMB price was down -2.71% on Mar 7, 2025

Price YTD Change

-30.46%
ASMB price is down -30.46% since January 1st

Price 3-Year Change

-39.04%
ASMB price is down -39.04% over the past 3 years

Market cap

Market Cap

$70.68 M
ASMB market capitalization is $70.68 million

Market Cap 3-Year Change

-3.36%
ASMB market capitalization is down -3.36% over the past 3 years

Market Cap All-time High

$1.30 B
ASMB market capitalization is currently -94.56% below its historical high of $1.30 billion

Market Cap Sector Rank

41.07%
ASMB market capitalization is higher than 41.07% of companies in Healthcare sector

Technical

Beta

-
ASMB beta value is unknown

200-day SMA

$15.19
ASMB price is currently -26.78% below its 200-day simple moving average

14-day RSI

-
ASMB 14-day relative strength index value is unknown

30-day Relative Volume

1.45
ASMB 30-day relative volume is 1.45

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$7.16 M
ASMB annual revenue is $7.16 million

Annual Revenue Analysts Estimate

$28.21 M
ASMB annual revenue is currently -74.61% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-
ASMB annual revenue 1-year change is unknown

Annual Revenue Sector Rank

25.37%
ASMB annual revenue is higher than 25.37% of companies in Healthcare sector

Profit

Annual Gross Profit

-
ASMB annual gross profit value is unknown

Annual Gross Margin

-
ASMB annual gross profit margin value is unknown

Annual Operating Profit

-$64.65 M
ASMB annual operating income is -$64.65 million

Annual Operating Margin

-902.50%
ASMB annual operating profit margin is -902.50%

Annual Net Income

-$61.23 M
ASMB annual net profit is -$61.23 million

Annual Net Margin

-854.78%
ASMB annual net profit margin is -854.78%

EPS

Annual EPS

-$13.38
ASMB annual earnings per share is -$13.38

Annual EPS Analysts Estimate

-$6.87
ASMB annual earnings per share is currently +94.76% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+42.03%
ASMB annual earnings per share is up +42.03% year-on-year

Annual EPS Sector Rank

12.65%
ASMB annual earnings per share is higher than 12.65% of companies in Healthcare sector

ROA & ROE

Annual ROA

-51.32%
ASMB annual return on assets is -51.32%

Annual ROE

-98.95%
ASMB annual return on equity is -98.95%

EBIT & EBITDA

Annual EBIT

-$64.65 M
ASMB annual earnings before interest & taxes is -$64.65 million

Annual EBITDA

-$64.20 M
ASMB annual EBITDA is -$64.20 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ASMB price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ASMB price to earnings ratio is unknown

PB Ratio

PB Ratio

2.72
ASMB price to book ratio is 2.72

PB Ratio Sector Rank

67.79%
ASMB price to book ratio is higher than 67.79% of companies in Healthcare sector

PS Ratio

PS Ratio

2.50
ASMB price to sales ratio is 2.50

PS Ratio Sector Rank

45.24%
ASMB price to sales ratio is higher than 45.24% of companies in Healthcare sector

Enterprise value

Enterprise Value

$43.67 M
ASMB enterprise value is $43.67 million

Enterprise Value Sector Rank

38.76%
ASMB enterprise value is higher than 38.76% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.94
ASMB EV/EBITDA is -0.94

EV/EBITDA Sector Rank

46.41%
ASMB EV/EBITDA is higher than 46.41% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.41
ASMB annual current ratio is 3.41

Annual Quick Ratio

-
ASMB annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
ASMB annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
ASMB annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ASMB piotroski f-score value is unknown

Altman Z-Score

-8.27
ASMB altman z-score is -8.27

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$136.82 M
ASMB annual total assets is $136.82 million

Annual Non Current Assets

$3.04 M
ASMB annual long term assets is $3.04 million

Annual Current Assets

$133.79 M
ASMB annual total current assets is $133.79 million

Annual Cash & Cash Equivalents

$19.84 M
ASMB annual cash & cash equivalents is $19.84 million

Equity

Annual Book Value

$41.10 M
ASMB annual book value is $41.10 million

Annual Working Capital

$94.56 M
ASMB annual working capital is $94.56 million

Liabilities

Annual Total Liabilities

$95.73 M
ASMB annual total liabilities is $95.73 million

Annual Total Long Term Liabilities

$56.50 M
ASMB annual total long term liabilities is $56.50 million

Annual Current Liabilities

$39.23 M
ASMB annual total current liabilities is $39.23 million

Annual Accounts Payable

$461.00 K
ASMB annual accounts payable is $461.00 thousand

Debt

Annual Total Debt

$2.34 M
ASMB annual total debt is $2.34 million

Annual Total Debt 1-Year Change

-32.41%
ASMB annual total debt is down -32.41% year-on-year

Annual Long Term Debt

$1.12 M
ASMB annual long term debt is $1.12 million

Annual Short Term Debt

$1.22 M
ASMB annual short term debt is $1.22 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$71.81 M
ASMB annual total expenses is $71.81 million

Annual Operating Expenses

$71.81 M
ASMB annual total operating expenses is $71.81 million

Annual Cost Of Goods Sold

-
ASMB annual cost of goods sold value is unknown

Annual SGA

$22.91 M
ASMB annual SGA is $22.91 million

Annual D&A

$450.00 K
ASMB annual depreciation & amortization is $450.00 thousand

Annual Interest Expense

-
ASMB annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$22.74 M
ASMB annual cash flow from operations is $22.74 million

Annual CFO 1-Year Change

+126.93%
ASMB annual cash flow from operations is up +126.93% year-on-year

Annual CFI

-$69.14 M
ASMB annual cash flow from investing activities is -$69.14 million

Annual CFI 1-Year Change

-176.28%
ASMB annual cash flow from investing activities is down -176.28% year-on-year

Annual CFF

$13.82 M
ASMB annual cash flow from financing activities is $13.82 million

Annual CFF 1-Year Change

+2150.49%
ASMB annual cash flow from financing activities is up +2150.49% year-on-year

Free CashFlow

Annual FCF

$22.49 M
ASMB annual free cash flow is $22.49 million

Annual FCF 1-Year Change

+126.59%
ASMB annual free cash flow is up +126.59% year-on-year

CAPEX

Annual CAPEX

$255.00 K
ASMB annual capital expenditures is $255.00 thousand

Annual CAPEX 1-Year Change

+150%
ASMB annual capital expenditures is up +150% year-on-year

Institutional Ownership

Similar stocks

VOR logo
Vor Biopharma (VOR)
CLSD logo
Clearside Biomedical (CLSD)
GUTS logo
Fractyl Health (GUTS)
INO logo
Inovio Pharmaceuticals (INO)
HYPR logo
Hyperfine (HYPR)
EPIX logo
ESSA Pharma (EPIX)
THTX logo
Theratechnologies (THTX)
CUE logo
Cue Biopharma (CUE)
ENTX logo
Entera Bio (ENTX)

FAQ

  • What is the ticker symbol for Assembly Biosciences?
  • Does Assembly Biosciences pay dividends?
  • What sector is Assembly Biosciences in?
  • What industry is Assembly Biosciences in?
  • What country is Assembly Biosciences based in?
  • When did Assembly Biosciences go public?
  • Is Assembly Biosciences in the S&P 500?
  • Is Assembly Biosciences in the NASDAQ 100?
  • Is Assembly Biosciences in the Dow Jones?
  • When was Assembly Biosciences's last earnings report?
  • When does Assembly Biosciences report earnings?
  • Should I buy Assembly Biosciences stock now?

What is the ticker symbol for Assembly Biosciences?

The ticker symbol for Assembly Biosciences is NASDAQ:ASMB

Does Assembly Biosciences pay dividends?

No, Assembly Biosciences does not pay dividends

What sector is Assembly Biosciences in?

Assembly Biosciences is in the Healthcare sector

What industry is Assembly Biosciences in?

Assembly Biosciences is in the Biotechnology industry

What country is Assembly Biosciences based in?

Assembly Biosciences is headquartered in United States

When did Assembly Biosciences go public?

Assembly Biosciences's initial public offering (IPO) was on December 17, 2010

Is Assembly Biosciences in the S&P 500?

No, Assembly Biosciences is not included in the S&P 500 index

Is Assembly Biosciences in the NASDAQ 100?

No, Assembly Biosciences is not included in the NASDAQ 100 index

Is Assembly Biosciences in the Dow Jones?

No, Assembly Biosciences is not included in the Dow Jones index

When was Assembly Biosciences's last earnings report?

Assembly Biosciences's most recent earnings report was on Nov 7, 2024

When does Assembly Biosciences report earnings?

The next expected earnings date for Assembly Biosciences is Mar 28, 2025

Should I buy Assembly Biosciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions